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Abstract
The elongation factor Tu (EF-Tu), an abundant bacterial protein involved in protein synthesis, has been shown to
display moonlighting activities. Known to perform more than one function at different times or in different places, it is
found in several subcellular locations in a single organism, and may serve as a virulence factor in a range of
important human pathogens. Here we demonstrate that Leptospira EF-Tu is surface-exposed and performs
additional roles as a cell-surface receptor for host plasma proteins. It binds plasminogen in a dose-dependent
manner, and lysine residues are critical for this interaction. Bound plasminogen is converted to active plasmin, which,
in turn, is able to cleave the natural substrates C3b and fibrinogen. Leptospira EF-Tu also acquires the complement
regulator Factor H (FH). FH bound to immobilized EF-Tu displays cofactor activity, mediating C3b degradation by
Factor I (FI). In this manner, EF-Tu may contribute to leptospiral tissue invasion and complement inactivation. To our
knowledge, this is the first description of a leptospiral protein exhibiting moonlighting activities.
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Introduction
Pathogenic microorganisms are able to penetrate and
colonize host tissues by establishing complex interactions with
host molecules. Surface proteins mediate binding of microbial
pathogens to an array of host targets such as cell receptors,
extracellular matrix components, coagulation cascade
molecules and complement regulators. This process enables
pathogens to disseminate to multiple organs and to evade host
´s innate immune response.
Recent reports have attributed unexpected functions to
cytosolic bacterial proteins normally involved in key metabolic
processes or in the cell stress response (reviewed in 1). Known
as “moonlighting” proteins, they execute multiple and unrelated
functions, and are found in several subcellular locations in a
single organism. By performing diverse cellular functions
related to adhesion, invasion and modulation of the host
immune system, this intriguing class of proteins may contribute
to virulence of important pathogens [1,2]. Enzymes of the
glycolytic pathway and of other metabolic pathways such as
the glyoxylate cycle, usually expressed at high levels, are good
examples of proteins that moonlight in bacteria. Molecular
chaperones and proteins involved in protein synthesis may also
perform multiple functions in some microorganisms [1].
The elongation factor Tu (EF-Tu) is an abundant bacterial
protein identified as a carrier of aa-tRNA to the ribosome, a
function associated with hydrolysis of the bound GTP [3].
Besides its role in protein synthesis, a panoply of functions has
been proposed for EF-Tu, including chaperone activity [4] and
catalyzation of protein disulfide formation, reduction, and
isomerization (refolding of randomly oxidized RNase) [5]. EF-
Tu has been described to be cell surface associated in several
prokaryotes, contributing to adhesion and invasion processes.
In Mycoplasma pneumonia EF-Tu mediates binding to
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fibronectin [6], and in Lactobacillus johnsonii it is implicated in
the attachment to human intestinal cells and mucins [7].
Interaction of EF-Tu with the human complement regulator FH
and with plasminogen has been reported for Pseudomonas
aeruginosa, thus facilitating bacterial immune evasion and
tissue invasion [8].
Spirochetes from the genus Leptospira are the aetiological
agent for leptospirosis, a neglected infectious disease that
constitutes a major public health problem in developing
countries. Once inside the host, pathogenic leptospires are
able to spread and colonize multiple organs. Invasiveness is
attributed to their ability to circumvent host´s innate immune
response and adhere to host cells and extracellular matrices
(reviewed in 9). Leptospires are also capable of binding and
activating plasminogen on their surfaces [10,11]. Once
converted to its active serine protease form (plasmin), this key
enzyme of the coagulation system is crucial for blood clot
resolution by dissolving fibrin polymers. Plasmin also degrades
extracellular matrix macromolecules including the glycoproteins
fibronectin, laminin, and elastin as well as proteoglycans [12].
Recently, plasmin has been characterized as a complement
inhibitor by cleaving the key proteins C3b and C5 [13]. The
surface protein E from Haemophilus influenzae acquires
human plasminogen that, once converted to plasmin, allows
the bacterium to control complement by degrading C3b [14].
Given the role of EF-Tu in bacterial adhesion, invasion and
immune evasion, our goal in the present study was to
characterize this multitask protein in Leptospira. We
demonstrate that leptospiral EF-Tu is highly conserved among
diverse species and is surface localized. Moreover, it is a FH-
and a plasminogen-binding protein. Bound to EF-Tu,
plasminogen is converted to plasmin, which in turn cleaves the
central human complement protein C3b as well as the
coagulation cascade molecule fibrinogen. In this manner, EF-
Tu may aid leptospires to disseminate throughout host tissues
and to evade innate immunity.
Materials and Methods
Ethics Committee Approval
Animals were supplied with food and water ad libitum and
experimental protocols were previously approved by the Ethical
Committee for Animal Research of the Faculdade de Medicina
Veterinária and Zootecnia, Universidade de São Paulo, São
Paulo, Brazil, under the license number 2385/2011.
Bacterial strains and plasmids
Leptospira biflexa serovar Patoc strain Patoc I, Leptospira
noguchii serovar Panama strain CZ 214K, Leptospira
borgpetersenii serovar Javanica strain Veldrat Batavia 46,
Leptospira borgpetersenii serovar Tarassovi strain 17,
Leptospira kirschneri serovar Cynopteri strain 3522C,
Leptospira interrogans serovar Copenhageni strain 10A,
Leptospira interrogans serovar Copenhageni strain L1-130,
Leptospira interrogans serovar Pomona strain Pomona, and
Leptospira santarosai serovar Shermani strain 1342K were
used in the assays. Bacteria were cultured at 29°C under
aerobic conditions as previously described [15]. Escherichia
coli DH5α was used as the cloning host strain and E. coli BL21
(DE3) was used as the host strain for the expression of the
recombinant proteins, using the T7 promoter based expression
plasmid pAE [16].
Purified proteins, sera and antibodies
All macromolecules from the extracellular matrix (ECM) were
purchased from Sigma-Aldrich. Laminin-1 and collagen Type IV
were derived from the basement membrane of Engelbreth-
Holm-Swarm mouse sarcoma, cellular fibronectin was derived
from human foreskin fibroblasts, plasma fibronectin was
isolated from human plasma, collagen Type I was isolated from
rat tail, and elastin from human aorta. Fibrinogen and
plasminogen were isolated from human plasma. Human FH,
C3b and FI were purchased from Complement Technology.
Normal human sera (NHS) were obtained from healthy donors.
The sera were pooled, and stored in aliquots at -80°C until use.
Goat anti-human FH was purchased from Quidel, goat anti-
human C3 polyclonal antibody was purchased from
Complement Technology and secondary peroxidase-
conjugated antibodies from Sigma-Aldrich. Mouse monoclonal
anti-human fibrinogen was purchased from BD Biosciences.
Cloning, expression, purification of recombinant
proteins and generation of antiserum
The tuf gene (LIC12875) was amplified by PCR from
genomic DNA of L. interrogans serovar Copenhageni strain
10A using the primers: F:CGCTCGAGGCTAAAGAAAAG /
R:GCGAAGCTTTTACTCAGTG. PCR fragments were cloned
into pGEM T-Easy vector (Promega) and transformed into E.
coli DH5α. Following digestion with restriction enzymes Xho I
and Hind III, fragments were subcloned into the E. coli
expression vector pAE. Expression and purification of the
resulting 6XHis-tagged recombinant protein were performed as
previously described [17]. The protein was purified from the
supernatant, and also from the insoluble pellet by nickel affinity
chromatography. LIC10301, LipL32 and LigBC were expressed
and purified as previously described [15,18]. The pAE-lipl32
construct was kindly provided by Dr. Paulo Lee Ho (Instituto
Butantan, São Paulo, Brazil). Antisera were produced in mice
[17].
Surface immunofluorescence assay
This assay was performed as previously described [19] with
slight modifications. Briefly, a 250 µL suspension of 1 x 108 L.
interrogans serovar Copenhageni strain L1-130 was added to
each well of Lab-Tek eight-well chamber slides (Nalge Nunc).
Following a 80 min-incubation at 30°C, unbound leptospires
were carefully removed, and adhered bacteria were fixed with
2% paraformaldehyde in PBS. Slides were incubated for 90
min at 30°C in blocking buffer (Difco Leptospira Enrichment
EMJH, BD). Immune and pre-immune sera (1:50) were diluted
in blocking buffer and slides were incubated for 60 min at 30°C.
After three washes with PBS, Alexa Fluor 488-labeled goat
anti-mouse IgG (Invitrogen / Molecular Probes) diluted 1:500 in
blocking buffer was added to the slides. Incubation proceeded
for 45 min at 30°C, and the slides were washed twice with PBS
and once with sterile water. The chambers were removed and
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the slides were mounted with Vectashield medium containing
propidium iodide (Vector Laboratories). Images were collected
using a LSM 510 (Zeiss) laser scanning confocal microscope.
Immunogold labeling and negative staining
L. interrogans serovar Copenhageni strain L1-130 fixed with
0.3% glutaraldehyde in PBS were firstly blocked with PBS
containing 0.2% bovine serum albumin (PBS/BSA) for 30 min,
and then incubated for 1h at room temperature with anti-EF-Tu
or preimmune serum (negative control) diluted 1:10 in PBS/
BSA. After washings with PBS, preparations were incubated
with goat anti-mouse antibody labeled with 10 nm colloidal gold
particles (Sigma-Aldrich, Co., USA) diluted 1:5 in PBS/BSA for
another hour, at room temperature. After washings with PBS
and distilled water, preparations were negatively stained with
2% uranyl acetate, applied onto Formvar-coated nickel grids for
2 min, air dried, and observed under TEM (LEO 906E - Leica
Microsystems BmgH, Germany) at 80 kV.
Binding of EF-Tu to ECM and coagulation cascade
molecules
EF-Tu attachment to individual macromolecules was
analyzed by an ELISA-based assay according to a previously
published protocol [17]. LigBC and LIC10301 were used as
positive and negative controls, respectively. Bound proteins
were detected with specific mouse antisera (1:10000). To
determine the role of lysines in EF-Tu plasminogen
interactions, ELISA plate wells were coated with recombinant
EF-Tu (10 µg/mL). The same protocol mentioned above was
followed except that ε-aminocaproic acid (0 - 10 mM) was
added with plasminogen (10 µg/mL) to EF-Tu-coated wells.
Bound plasminogen was detected with a mouse monoclonal
antibody (Sigma-Aldrich) at a 1:500 dilution followed by
peroxidase-conjugated anti-mouse IgG (Sigma-Aldrich) at a
1:5000 dilution. Student´s two-tailed t test was used for
statistical analyses. A P value less than 0.05 was considered
statistically significant.
Plasmin activity after plasminogen activation
Microtiter plate wells were coated with recombinant proteins
(10 µg/mL). After blocking with 3% BSA diluted in PBS,
plasminogen (20 µg/mL) was added and incubation proceeded
for 1 h at 37° C. Unbound plasminogen was removed by
washing wells three times with PBS-0.05% Tween, pH 7.4
(PBS-T), and then human urokinase plasminogen activator
(uPA) (3 U) and the chromogenic substrate D-valyl-leucyl-
lysine-ρ-nitroanilide dihydrochloride (25 µg/well) dissolved in
PBS were added. The plates were incubated at 37° C and
absorbance at 405 nm was read after 24 h.
Fibrinogen and C3b degradation assay
Recombinant proteins (10 µg/mL) were immobilized onto
microtiter plate wells. After blocking with 3% BSA diluted in
PBS, plasminogen (20 µg/mL) was added and incubation
proceeded for 1 h at 37° C. Wells were washed with PBS-T
and human fibrinogen (500 ng, plasminogen depleted;
Calbiochem) or human C3b (500 ng) together with
plasminogen activator uPA (3 U) were added. Reaction
mixtures were incubated at 37° C for the indicated time points,
and were then separated by SDS-PAGE and transferred to
nitrocellulose membranes. The degradation products were
detected by Western blotting using a mouse monoclonal anti-
human fibrinogen α-chain (1:3000) or a goat polyclonal anti-
human C3 (1:10000) and the corresponding secondary
horseradish phosphatase-conjugated antibodies. Membranes
were developed with SuperSignal West Pico (Pierce).
Interaction of EF-Tu with FH by ligand affinity blotting
Purified recombinant proteins were subjected to 10% SDS–
PAGE under nonreducing conditions and transferred to
nitrocellulose membranes. The membranes were incubated for
90 min with 7% normal human serum as a source of FH diluted
in PBS. After washing, the membranes were incubated with
polyclonal goat antibodies recognizing human FH (1:10000),
followed by peroxidase-conjugated secondary antibodies
(1:10000). Positive signals were detected by enhanced
chemiluminescence (West Pico, Pierce). LigBC and LIC10301
were used as positive and negative controls respectively [18].
Cofactor assay
Cofactor activity of FH bound to EF-Tu was analyzed by
measuring FI-mediated cleavage of C3b essentially as
described by 18. LigBC and LIC10301 were used as positive
and negative controls respectively [18].
Immunoblot analysis
Leptospira extracts were fractionated on a 12% SDS–PAGE
and transferred to nitrocellulose membranes. Nonspecific
binding sites were blocked by using 10% (wt/vol) dried milk in
PBST overnight at 4° C. After washing three times with PBS-T,
the membranes were incubated with mouse anti-EF-Tu serum
(diluted 1:1000) in 5% non-fat dried milk–PBST for 60 min.
Following three washes with PBST, the membranes were
incubated with a secondary peroxidase-conjugated anti-mouse
IgG for 60 min at room temperature at a 1:5000 dilution,
washed, and revealed with ECL reagent (West Pico, Pierce).
Results
EF-Tu is a surface protein of Leptospira
Proteins supposed to have multiple functions may display
more than one subcellular localization. In order to assess if EF-
Tu is associated to the leptospiral membrane, we performed
immunofluorescence assays with intact bacteria. Leptospires
were cultured until they reached a density of 1 x 108 cells/mL
and were then added to the slides. To avoid outer membrane
disruption, the initial centrifugation step, normally used to
harvest and concentrate the bacteria [19], was abolished. Our
results revealed that EF-Tu was recognized by anti-EF-Tu
mouse serum (Figure 1A). Positive control experiments were
performed with antibodies recognizing the conserved N-
terminal portion shared by LigA and LigB (anti-LigA/B mouse
serum), known to be surface-exposed proteins [20], and
preimmune mouse serum was used as a negative control
Leptospira EF-Tu Binds Plasminogen and FH
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(Figure 1A). EF-Tu surface localization was further assessed
by immunoelectron microscopy. Immunogold labeling of L.
interrogans cells was consistently observed with antiserum
against EF-Tu, while organisms incubated with preimmune
serum did not present bound colloidal-gold particles (Figure
1B).
EF-Tu interacts with ECM components and coagulation
cascade molecules
Once EF-Tu is associated to the leptospiral membrane, we
next investigated its ability to interact with host molecules such
as ECM and coagulation cascade components. According to
our ELISA binding assays, EF-Tu interacted will all ECM
Figure 1.  Cellular localization of EF-Tu on Leptospira interrogans.  (A) Surface immunofluorescence assay was performed
using confocal microscopy (Zeiss LSM-510 Meta). Intact leptospires were probed with anti-EF-Tu, anti-LigA/B or preimmune mouse
serum. Alexa Fluor 488 conjugated goat anti-mouse IgG was used to detect bound antibodies. A iodide propidium counterstain (low
panels) was used to demonstrate the presence of leptospires. (B) Immunoelectron microscopy analysis. Leptospires were incubated
with anti-EF-Tu or pre-immune mouse serum, followed by treatment with colloidal-gold-conjugated anti-mouse IgG. Analysis was
performed using an electron transmission microscope (LEO 906E - Leica Microsystems BmgH, Germany).
doi: 10.1371/journal.pone.0081818.g001
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macromolecules tested. Binding to fibrinogen and plasminogen
was also observed. EF-Tu did not bind to fetuin, included as a
highly glycosylated attachment-negative control protein (Figure
2). Interestingly, LigBC, our positive control previously shown
to bind multiple ECM macromolecules [21-28], strongly
interacted with fetuin, but no specific binding to the target
molecules was detected with the negative control protein
LIC10301 (Figure 2).
Role of lysine residues in EF-Tu binding to
plasminogen
According to the results shown in Figure 2, plasminogen is
one of the target host molecules for EF-Tu. To further
characterize this interaction, we performed a second ELISA
binding assay using increasing amounts of recombinant EF-Tu.
From this assay we conclude that EF-Tu binds plasminogen in
Figure 2.  Binding of EF-Tu to ECM components.  Wells
were coated with 10 μg/mL of collagen type I (CI), collagen
type IV (CIV), cellular fibronectin (FC), plasma fibronectin (FP),
laminin (LAM), elastin (ELA), fibrinogen (FIB), plasminogen
(PLG) and the control protein fetuin (FET). Recombinant
protein attachment to those ECM macromolecules was
assessed by ELISA. One microgram of recombinant EF-Tu
protein was added per well. LigBC and LIC10301 were
included as positive and negative controls, respectively. LipL32
was included as a positive control for plasminogen [34]. Bound
proteins were detected using mouse specific antisera to the
recombinant proteins, followed by peroxidase-conjugated
secondary antibodies. Each point represents the mean
absorbance value at 492 nm ± the standard deviation of three
independent experiments, each performed in duplicate. Binding
of EF-Tu to each ECM component was compared to the
binding of LIC10301 to these molecules by the two-tailed t test
(* p < 0.05).
doi: 10.1371/journal.pone.0081818.g002
a dose-dependent and saturable manner (Figure 3A).
Apparently, lysine residues are relevant to plasminogen-EF-Tu
interactions as the lysine analog ε-aminocaproic acid partially
inhibited plasminogen binding (Figure 3B).
Plasminogen bound to EF-Tu is converted to plasmin
To assess if EF-Tu-bound plasminogen could be converted
to active plasmin by exogenously supplied uPA, immobilized
EF-Tu was incubated with plasminogen. After extensive
washing, uPA and the chromogenic substrate D-valyl-leucyl-
lysine-ρ-nitroanilide dihydrochloride were added. The newly
generated plasmin was able to cleave the chromogenic
substrate (Figure 4).
Figure 3.  Binding of leptospiral EF-Tu to human
plasminogen.  (A) Binding of EF-Tu to plasminogen as a
function of protein concentration by ELISA. EF-Tu and the
positive and negative control proteins LipL32 and LIC10301 (0
- 2 μM) were allowed to interact with immobilized plasminogen
(10 μg/mL), and were detected using specific antisera, followed
by peroxidase-conjugated secondary antibodies. (B) Role of
lysines in EF-Tu/plasminogen interaction. Plasminogen (10
μg/mL) was added to EF-Tu-coated wells in the presence (0.1 -
10 mM) or absence of ε-aminocaproic acid. Bound
plasminogen was detected with a specific monoclonal antibody
followed by peroxidase-conjugated anti-mouse IgG. In (A) and
(B) each point represents the mean absorbance value at 492
nm ± the standard deviation of three independent experiments,
each performed in duplicate. (* p < 0.05). .
doi: 10.1371/journal.pone.0081818.g003
Leptospira EF-Tu Binds Plasminogen and FH
PLOS ONE | www.plosone.org 5 November 2013 | Volume 8 | Issue 11 | e81818
Plasmin bound to EF-Tu cleaves C3b and fibrinogen
Besides its function in fibrinolysis, the serine protease
plasmin plays a crucial role in degrading extracellular matrix
components. It is also capable of cleaving the complement
proteins such as the fragment C3b [13]. We then assayed
whether EF-Tu-bound plasmin(ogen) was able to cleave the
natural substrate fibrinogen and also C3b. The fibrinogen α-
chain was degraded in a time-dependent manner, and
cleavage was almost complete after 4 hours of incubation
(Figure 5A). Proteolytic activity of EF-Tu-bound plasmin was
also observed against C3b. Cleavage was time dependent,
being more pronounced after 5 hours of incubation (Figure 5B).
In both assays LipL32 was included as a positive control.
According to our results, LipL32-bound plasmin(ogen) was able
to degrade fibrinogen as efficiently as EF-Tu-bound
plasmin(ogen) (Figure 5A). However, C3b cleavage was less
pronounced when we used LipL32 (Figure 5B).
EF-Tu binds FH and bound-FH retains co-factor activity
It has been demonstrated that EF-Tu from the Gram-
negative bacterium Pseudomonas aeruginosa binds
plasminogen and the human complement regulator FH [8]. This
observation prompted us to evaluate the interaction of
leptospiral EF-Tu with FH. Binding was assessed by ligand
affinity blot using soluble FH from human sera. As depicted in
Figure 6A, FH bound to EF-Tu. LigBC and LIC10301 were
Figure 4.  EF-Tu-bound plasminogen is converted to
functionally active plasmin.  Recombinant proteins or BSA
(10 μg/mL), immobilized to microtiter plate wells, were
incubated with plasminogen (20 μg/mL). After washing, uPA (3
U) and the chromogenic substrate D-valyl-leucyl-lysine-ρ-
nitroanilide dihydrochloride (25µg/well) were added. Data
represent the mean absorbance value at 405 nm ± the
standard deviation of three independent experiments, each
performed in duplicate. (* p < 0.05). .
doi: 10.1371/journal.pone.0081818.g004
Figure 5.  Degradation of human fibrinogen and C3b by
plasmin(ogen) bound to immobilized EF-Tu.  Plasminogen
(20 µg/mL) was added to immobilized recombinant proteins (10
µg/mL). After washing, fibrinogen (500 ng) (A) or C3b (500 ng)
(B) and uPA (3 U) were added, and incubation proceeded for
the indicated time points. Samples were separated by SDS-
PAGE, transferred to a nitrocellulose membrane, and probed
with a mouse monoclonal antibody recognizing the fibrinogen
α-chain (A) or a goat polyclonal anti-human C3 (B) followed by
the corresponding secondary HRP-conjugated antibodies.
Controls omitting uPA and/or plasminogen were included.
doi: 10.1371/journal.pone.0081818.g005
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included as positive and negative controls respectively [18]. To
assess the functional activity of bound-FH, EF-Tu and the
control recombinant proteins were immobilized and incubated
with purified FH. After washing, C3b and FI were added. The
cleavage products of C3b were detected by Western blotting
using anti-human C3 polyclonal antibodies. FH bound to EF-Tu
retained cofactor activity, as indicated by the presence of
representative C3b cleavage products (α’68 kDa and α’43
kDa). As expected, a similar profile was observed for LigBC.
No cleavage products were detected for LIC10301 (Figure 6B).
Ubiquitous distribution of EF-Tu protein in Leptospira
spp
Anti-EF-Tu serum was used to screen a panel of Leptospira
extracts. A band of 43 kDa, corresponding to the expected size
of native EF-Tu, was observed in all the pathogenic serovars
tested (serovars Panama, Javanica, Tarassovi, Cynopteri,
Copenhageni, Pomona and Shermani), and was also observed
in the non-pathogenic saprophytic L. biflexa serovar Patoc
(Figure 7). Hence, EF-Tu is ubiquitously distributed among
Leptospira species. Multiple sequence alignment has shown
that EF-Tu from pathogenic Leptospira strains is highly
conserved (99-100% identity at the amino acid level). L.
interrogans Copenhageni L1-130 and L. biflexa Patoc1 EF-Tu
share 86% sequence identity. Comparison of surface EF-Tu
functions in various microorganisms indicates that this
moonlighting protein interacts with host cells or molecules such
as complement regulators and/or extracellular matrix proteins,
and is highly conserved (Table 1).
Discussion
The Elongation Factor Tu is one of the most abundant and
conserved bacterial proteins. It belongs to a class referred to
as moonlighting proteins, known to perform multiple but
unrelated functions that cannot be ascribed to gene fusions,
splice variants or proteolytic fragments that serve different
activities [29]. Along with its traditional cytoplasmic function in
protein synthesis, we have demonstrated in this study that
Leptospira EF-Tu performs additional roles as a cell-surface
receptor for host plasma proteins. It remains unclear how EF-
Tu, which lacks classical sorting signals, is anchored at the
outer membrane of several prokaryotes, but it has been shown
that this additional surface location allows interaction of these
microorganisms with host cells and molecules such as
fibronectin [6,30], plasminogen [8,31], FH [8], mucins and
human intestinal cells [7].
Efficient colonization of target organs by pathogenic
leptospires is achieved by their capacity to escape host innate
immune responses [32,33] and, subsequently, through their
ability to interact with host cells or with the extracellular matrix
(reviewed in 9). Our immunofluorescence and immunoelectron
microscopy assays indicate that Leptospira EF-Tu is surface
localized. We then wondered whether this protein would also
“moonlight”, thus contributing to leptospiral invasiveness.
According to our results, EF-Tu mediates interaction with
extracellular matrix and coagulation cascade molecules,
including collagen I and IV, cellular and plasma fibronectin,
Figure 6.  Leptospiral EF-Tu interacts with the complement
regulator FH and bound-FH remains functionally
active.  (A) Purified recombinant proteins were subjected to
SDS–PAGE, and transferred to a nitrocellulose membrane.
The membrane was incubated with 7% NHS as a source of FH,
and probed with polyclonal goat antibodies recognizing human
FH, followed by secondary HRP-conjugated antibodies. LigBC
(56 kDa) and LIC10301 (13 kDa) were included as positive and
negative controls, respectively. (B) Cofactor activity of FH
bound to EF-Tu. The recombinant proteins EF-Tu, LigBC, and
LIC10301 (10 μg/mL) were immobilized on microtiter plates
and incubated with purified FH (2 μg). Control reactions in
which we omitted FH were also included. After washing, C3b
and FI were added. The reactions were incubated for 1, 2, and
4 h at 37°C. The products were analyzed by SDS-PAGE and
the cleavage fragments of C3b were detected by Western
blotting with anti-human C3 polyclonal. The presence of bands
of 43 and 68 kDa indicates that acquired FH was able to
promote FI-mediated cleavage of C3b. LIC10301 was used as
a negative control since this protein does not bind FH and
LigBC was included as a positive control [18].
doi: 10.1371/journal.pone.0081818.g006
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laminin, elastin, fibrinogen and plasminogen. A proteomic
approach employing total protein extracts of L. interrogans had
already identified EF-Tu as a plasminogen-binding protein [34],
what prompted us to further characterize this interaction. In
agreement to previous published data, Leptospira EF-Tu bound
human plasminogen in a dose-dependent manner. Ionic
interactions do not seem to play a role in EF-Tu-plasminogen
interaction, since different concentrations of NaCl did not affect
binding (data not shown). Conversely, addition of ε-
aminocaproic acid reduced the interaction between EF-Tu and
Figure 7.  Immunoblot analysis with EF-Tu antiserum to
different Leptospira species.  Lanes contain whole-cell
lysates of L. biflexa serovar Patoc (lane 1), L. noguchii serovar
Panama (lane 2), L. borgpetersenii serovar Javanica (lane 3),
L. borgpetersenii serovar Tarassovi (lane 4), L. kirschneri
serovar Cynopteri (lane 5), L. interrogans serovar Copenhageni
(lane 6), L. interrogans serovar Pomona (lane 7), L. santarosai
serovar Shermani (lane 8), and recombinant EF-Tu (lane 9).
doi: 10.1371/journal.pone.0081818.g007
Table 1. Function of surface EF-Tu in different
microorganisms.
Microorganism
Function (associated
with surface
localization)
* % identity to L.
interrogans
Copenhageni
L1-130
* % similarity
to L.
interrogans
Copenhageni
L1-130
Pseudomonas
aeruginosa
Interaction whit
human
complement Factor
H and plasminogen
[8]
72% 86%
Francisella
novicida
Eliciting of
inflammatory
cytokine response
in macrophages
[41]
70% 85%
Listeria
monocytogenes
Interaction with
plasminogen [31] 72% 84%
Mycoplasma
pneumoniae
Interaction with
fibronectin [6; 42] 68% 80%
Lactobacillus
johnsonii
Binding to human
intestinal cells and
mucin [7]
66% 80%
*. Percent identity and similarity at the amino acid level was calculated using
BLASTp (http://blast.ncbi.nlm.nih.gov/).
doi: 10.1371/journal.pone.0081818.t001
plasminogen, thus suggesting a role for lysines in this process.
Once bound to EF-Tu, plasminogen is converted to functionally
active plasmin, which, in turn, is able to cleave the complement
protein C3b and the fibrinogen α-chain. Interestingly,
Leptospira EF-Tu also acquires FH, a 150-kDa plasma protein
that inhibits the alternative pathway of complement by
preventing binding of Factor B to C3b, accelerating decay of
the C3-convertase C3bBb and acting as a cofactor for the
cleavage of C3b by Factor I (FI) [35–37]. Importantly, FH is
capable of acting as a cofactor when bound to EF-Tu, as
indicated by the presence of C3b cleavage fragments after
incubation with FI. Therefore, by interacting with plasminogen
and FH, EF-Tu helps to control complement thus contributing
to leptospiral immune evasion. Moreover, EF-Tu-bound
plasmin(ogen) may also aid bacterial dissemination by
degrading the natural substrate fibrinogen.
EF-Tu is ubiquitously distributed among leptospiral serovars,
including the nonpathogenic L. biflexa serovar Patoc (Figure 7).
In Pseudomonas aeruginosa EF-Tu, described as a FH- and
plasminogen-binding protein, was identified in the surface
protein fraction of the serum-sensitive strain SG137 [8]. The
presence of EF-Tu in nonpathogenic bacteria does not warrant
their survival in the host, because the majority of pathogens
have generally adopted multiple evasion strategies for efficient
colonization. Recent published data by our group have
demonstrated that L. interrogans has both acquired and
endogenous complement regulatory activity with regard to C3b
degradation [18]. Leptospiral outer membrane proteins like
LenA, LenB, LigA, LigB and LcpA have been shown to
contribute to complement evasion [15,18,38,39]. Present only
in pathogenic species, these receptors acquire the host fluid-
phase regulators FH and/or C4b Binding Protein (C4BP), thus
aiding to control complement activation at the bacterium
surface. Moreover, pathogenic leptospires secrete proteases
that cleave key complement proteins of the three pathways,
thus conferring additional survival advantage in the host [Fraga
et al., unpublished data].
EF-Tu has been described as a potential vaccine antigen
against Burkholderia infection [40]. Given the wide distribution
of this protein among diverse Leptospira species, its usefulness
as a subunit vaccine candidate against pathogenic Leptospira
was assessed. EF-Tu did not elicit protection in hamsters
challenged with lethal doses of L. interrogans serovar
Copenhageni L1-130 (data not shown).
In conclusion, we identified EF-Tu as a leptospiral
moonlighting protein. When displayed on the bacterium
surface, EF-Tu binds multiple host effector proteins, thus
contributing to tissue invasion and complement inactivation. To
our knowledge, this is the first description of a leptospiral
protein exhibiting moonlighting activities.
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